Cur: 0.33 0.0751 (29.5%) Vol:

New Post Public Reply Private Reply Replies (2) Message Board
RamTough2010 RamTough2010 #661
Cur: 0.33
0.0751
(29.5%)
Vol: 446,927
ANNOUNCEMENT(1)
1 75 0.31 - 0.33 49 1
05:32:10 CSTI 75 0.31
05:32:26 PERT 100 0.0001
05:32:08 WDCO 25 0.26
05:32:19 NITE 100 0.258
07:52:22 CDEL 71 0.255
05:32:12 PUMA 25 0.24
05:32:24 ETRF 100 0.085
05:32:22 CANT 100 0.071
05:32:24 BMIC 100 0.02
05:32:19 BMAK 100 0.01
05:32:21 VNDM 100 0.01
05:32:24 MAXM 100 0.01
05:32:07 VFIN 100 0.0001
0.33 49 ATDF 10:53:23
0.3399 35 NITE 05:32:19
0.34 142 CSTI 05:32:10
0.389 25 CDEL 07:52:22
0.45 25 WDCO 05:32:08
0.45 25 ETRF 05:32:24
0.49 25 PUMA 05:32:12
0.89 10 BMIC 05:32:24
0.92 10 CANT 05:32:22
0.92 250 PERT 05:32:26
1.00 1 BMAK 05:32:19
1.95 1 VNDM 05:32:21

ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Murphy Oil Inc.'s Price-to-Earnings Insights

Updated Category News Views 152

Understanding Murphy Oil Inc.'s Recent Market Performance Currently, Murphy Oil Inc. (NYSE: MUR) shares are valued at $30.88, exhibiting a minor rise of 0.06% in today's trading session. Observing the stock’s journey over the last month, we've seen a significant increase of 6.77%. However, when we take a closer look at the past year, the stock has unfortunately dropped...

Continue Reading
Marco Pharma: 35 Years of Principle Over Profits

Updated Category News Views 3

Keeping Principles Alive in a Competitive Market In an industry where folks often chase the latest trend like seagulls after a fish fry, Marco Pharma International stands its ground on principles rather than profits. It's rare to see a company, especially in the natural health sector, keeping its roots this deep for 35 years. And they're not just talking about it—this...

Continue Reading
Rakovina Therapeutics Unveils AI-Enhanced ATR Inhibitors Breakthrough

Updated Category News Views 188

Rakovina Therapeutics Presents AI-Developed ATR Inhibitors Rakovina Therapeutics Inc. (TSXV: RKV) has made a significant impact at a recent international conference dedicated to cancer therapeutics. The conference gathered numerous leaders in the field, creating an excellent platform to unveil groundbreaking research. Presenting their innovative findings, Rakovina...

Continue Reading
Elon Musk Critiques FCC's Denial of Starlink Subsidy While Aiding Disaster Recovery

Updated Category News Views 334

Elon Musk Critiques FCC's Decision on Starlink Subsidy Elon Musk, the visionary CEO of SpaceX, has voiced his discontent over the FCC's recent ruling that denied approximately $885 million in subsidies to Starlink, the company's satellite internet service. Musk described this decision as "contemptible political lawfare," coinciding with FEMA's deployment of Starlink...

Continue Reading
Assessing the Resilience of American Consumers Amid Challenges

Updated Category News Views 130

Understanding the Current Landscape of American Consumers The state of the American consumer remains resilient despite facing numerous challenges, as reported by Barclays in its recent analysis. The approach to consumer spending in the latest quarter reflects a balancing act, with buyers maneuvering through both advantageous conditions and potential obstacles. Positive...

Continue Reading